Vol. 6 (04) pp. 1361-1365 DOI: 10.21474/IJAR01/6994

TO STUDY INDIVIDUAL AND COMBINED ANTIBIOTICS EFFICACY AGAINST RESISTANT PATHOGEN ISOLATED FROM DIABETIC FOOT INFECTION.

  • Shri. Dnyaneshwar Maskuji Burungale Science College, Shegaon. Dist. Buldana (MS).
9 Downloads 124 Views
Crossref

Download Full Paper (PDF)

Abstract

Diabetic foot infections typically begin in a wound, most often due to neuropathic ulceration. Diabetic foot infection facing unique challenge of successful treatment because of wide spread of resistant bacteria to many antibiotics. Combination antibiotic therapy could be helpful to combat these resistant bacteria. This basically depends on the microbial etiology and selection of appropriate antibiotics for combination therapy. Using manual E-test method, Minimum inhibitory concentration (MIC) was determined susceptibility to individual antibiotics. Fractional inhibitory concentration index (FICI) was used to determine synergistic effects for combined antibiotics. . Gentamicin susceptibility showed 100%, 20%, 30%, 80% and 70% of Escherichia coli, Klebsiella pneumonia, Proteus spp, Pseudomonas spp, and Staphylococcus aureus, were sensitive, respectively. Ciprofloxacine showed 80%, 30%, 60%, 40% and 90 % resistant to Escherichia coli, Klebsiella pneumonia, Proteus spp, Pseudomonas spp, and Staphylococcus aureus, respectively. Ceftriaxone showed 50%, 40% 60%, 10%, and 70% resistant result against Escherichia coli, Klebsiella pneumonia, Proteus spp, Pseudomonas spp, and Staporhylococcus aureus, respectively. Fractional inhibitory concentration index (FICI) recorded and synergistic effects were determined. Knowledge on the antibiotic synergy pattern of the iso?lates will be helpful in determining the drugs for the empirical treatment of diabetic foot infections.

Keywords

How to Cite This Article

Patil Y. S. (2018); TO STUDY INDIVIDUAL AND COMBINED ANTIBIOTICS EFFICACY AGAINST RESISTANT PATHOGEN ISOLATED FROM DIABETIC FOOT INFECTION., International Journal of Advanced Research (IJAR), 6 (04), 1361-1365, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/6994

Corresponding Author

Dr. Yamini Sadashiv Patil
Assist Proffesor

Article Analytics

References

  1. Akhtar, N., Alqurashi, A. M. and Abu Twibah, M. (2010). In vitro ciprofloxacin resistance profiles among gram-negative bacteria isolated from clinical specimens in a teaching hospital. J. Pak. Med. Assoc. 60, 625?7 (2010).
  2. Alavi SM, Khosravi AD, Sarami A, Dashtebozorg A, Montazeri EA. Bacteriologic study of diabetic foot ulcer. Pak J Med Sci 2007; 23: 681-4.
  3. Amitabha Bhattacharjee. Antimicrobial susceptibility of pseudomonas aeruginosa isolated from wound infections, Indian journal of dermatology. 2012, vol 51(4), 286-288.
  4. Anandi C, Alaguraja D, Natarajan V, Ramanathan M, Subramaniam CS, Thulasiram M, et al. Bacteriology of diabetic foot lesions. Indian J Med Microbiol 2004; 22: 175-8.
  5. Angehrn, P. (1983). In vitro and in vivo synergy between ceftriaxone and aminoglycosides against Pseudomonas aeruginosa. Eur. J. Clin. Microbiol. 2, 489?95 (1983).
  6. Anguzu, J. R. and Olila, D. (2007). Drug sensitivity patterns of bacterial isolates from septic post-operative wounds in a regional referral hospital in Uganda. Afr. Health Sci. 7, 148?54 (2007).
  7. Bahashwan, S. A. & Shafey, H. M. El. (2013). Antimicrobial resistance patterns of proteus isolates from clinical specimens. Eur. Sci. J. 9, 1857?788 (2013).
  8. Baron E J, Thomson RB. Specimen collection, transport and processing: bacteriology .manual of clinical microbiology. 2011, vol (10), 228-271.
  9. Bowler P G, Duerden B I, Armstrong DG .wound microbiology and associated approaches to wound management. Clin Microbiol. 2011, vol (14), 244-269.
  10. (2013). Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. Clinical and Laboratory Standards Institute 32, (2013).
  11. Crouzet, J., Lavigne, J. P., Richard, J. L. and Sotto, A (2011). Diabetic foot infection: a critical review of recent randomized clinical trials on antibiotic therapy. J. Infect. Dis. 15, e601?10 (2011).
  12. DiazGranados, C. A., Cardo, D. M. and McGowan, J. E. (2008). Antimicrobial resistance: international control strategies, with a focus on limited-resource settings. International Journal of Antimicrobial Agents 32, 1?9 (2008).
  13. Dickgiesser, N., in der Stroth, S. and Wundt, W. (1986). Synergism of ciprofloxacin with beta-lactam antibiotics, gentamicin, minocycline and pipemidic acid]. Infection 14, 82?5 (1986).
  14. Gadepalli R, Dhawan B, Sreenivas V, Kapil A, Ammini AC, Chaudhry R.A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diabetes Care 2006; 29: 1727-32.
  15. Kibret, M. & Abera, B. (2011). Antimicrobial susceptibility patterns of E. coli from clinical sources in northeast Ethiopia. Afr. Health Sci. 11 Suppl 1, S40?5 (2011).
  16. Leekha, S., Terrell, C. L. & Edson, R. S. (2011). General principles of antimicrobial therapy. Mayo Clin. Proc. 86, 156?67 (2011).
  17. Levy, S. B. (2002). Factors impacting on the problem of antibiotic resistance. Antimicrob. Chemother. 49, 25?30 (2002).
  18. Lowman, W., Aithma, N., Duse, A. G. and Mer, M. (2012). Comparative MIC evaluation of a generic ceftriaxone by both microdilution on clinically relevant isolates from an academic hospital complex in South Africa. South African Medical Journal 102, 102?103 (2012).
  19. Masood, S. H. and Aslam, N. (2010). In Vitro Susceptibility Test of Different Clinical Isolates against Ceftriaxone. Oman Med. J. 25, 199?202 (2010).
  20. Meletiadis, J., Pournaras, S., Roilides, E. and Walsh, T. J. (2010). Defining fractional inhibitory concentration index cutoffs for additive interactions based on self-drug additive combinations, Monte Carlo simulation analysis, and in vitro-in vivo correlation data for antifungal drug combinations against Aspergillus fumi. Agents Chemother. 54, 602?9 (2010).
  21. Nwankwo, E. O. and Nasiru, M. S. (2011). Antibiotic sensitivity pattern of Staphylococcus aureus from clinical isolates in a tertiary health institution in Kano, Northwestern Nigeria. Pan Afr. Med. J. 8, 4 (2011).
  22. Onyango LA, Dunstan RH, Gottfries J, von Eiff C, Roberts TK. (2012). Effect of Low Temperature on Growth and
  23. Salem-bekhit, M. M. Phenotypic and Genotypic Characterization of Nosocomial Isolates of Staphylococcus aureus with Reference to Methicillin Resistance. 13, 1239?1246 (2014).
  24. Samuelsen O, Haukland HH, Kahl BC, von Eiff C, Proctor RA, Ulvatne H, et al. (2005). Staphylococcus aureus small colony variants are resistant to the antimicrobial peptide lactoferricin B. J Antimicrob Chemother. 2005;56(6):1126-9.
  25. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA 2005; 293: 217-28.
  26. Ultra-Structure of Staphylococcus spp. PLoS One. 2012; 7(1): e29031. PubMed Central PMCID: PMC3265459.
  27. Weiss, D., Trautmann, M., Wagner, J., Borner, K. and Hahn, H. (1986). Ciprofloxacin: a comparative evaluation of its bactericidal activity in human serum against four enterobacterial species. Drugs Exp. Clin. Res. 12, 889?94 (1986).
  28. Yasmin, F., Akhtar, N. and Hameed, A. (2013). Report: In vitro synergistic Effect of Ciprofloxacin with Aminoglycosides against Multidrug resistant-Pseudomonas aeruginosa. Pak. J. Pharm. Sci. 26, 1041?4 (2013).

Similar Articles

Creative Commons Attribution 4.0 This work is licensed under a Creative Commons Attribution 4.0 International License.